Xiaoying Lou1, Yazan M Duwayri2, Edward P Chen1, William D Jordan2, Jessica Forcillo1, Carl A Zehner1, Bradley G Leshnower3. 1. Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia. 2. Division of Vascular and Endovascular Therapy, Emory University School of Medicine, Atlanta, Georgia. 3. Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia. Electronic address: bleshno@emory.edu.
Abstract
BACKGROUND: Optimal medical therapy (OMT) for uncomplicated type B aortic dissection (uTBAD) provides excellent short-term outcomes but is associated with a high incidence of failure. This study identified predictors of aortic intervention and mortality in uTBAD patients undergoing OMT. METHODS: A retrospective review of the Emory University School of Medicine aortic database identified 314 uTBAD patients undergoing OMT from 2000 to 2016. Two hundred sixty-three (84%) patients had imaging at presentation analyzed for maximum aortic diameters (ADs), false lumen (FL) status, and visceral vessel perfusion. Cox proportional hazards models were constructed to estimate hazards ratios (HRs) and identify predictors of OMT failure. RESULTS: The mean age of patients was 58 ± 12 years, and 67% were men. FL status was patent in 59.4%, partially thrombosed in 39.8%, and completely thrombosed in 0.8% of patients. Over a median follow-up of 5.6 (interquartile range, 1.4 to 8.5) years, 44.9% of patients failed OMT and underwent intervention (n = 58 open, n = 83 endovascular). The estimated incidence of OMT failure was 46%. Multivariate analysis identified the presence of diabetes, renal failure, DeBakey 3B dissection, and a descending thoracic AD of 4.5 cm or greater (HR, 1.39; 95% confidence interval, 1.24 to 1.56; p < 0.001) to be independent predictors of failure of OMT. FL status or the distribution of visceral vessels arising from the FL did not predict OMT failure. CONCLUSIONS: There is a significant incidence of OMT failure in uTBAD patients. A descending thoracic AD of 4.5 cm or greater at the time of diagnosis is an independent predictor of failure of OMT.
BACKGROUND: Optimal medical therapy (OMT) for uncomplicated type B aortic dissection (uTBAD) provides excellent short-term outcomes but is associated with a high incidence of failure. This study identified predictors of aortic intervention and mortality in uTBAD patients undergoing OMT. METHODS: A retrospective review of the Emory University School of Medicine aortic database identified 314 uTBAD patients undergoing OMT from 2000 to 2016. Two hundred sixty-three (84%) patients had imaging at presentation analyzed for maximum aortic diameters (ADs), false lumen (FL) status, and visceral vessel perfusion. Cox proportional hazards models were constructed to estimate hazards ratios (HRs) and identify predictors of OMT failure. RESULTS: The mean age of patients was 58 ± 12 years, and 67% were men. FL status was patent in 59.4%, partially thrombosed in 39.8%, and completely thrombosed in 0.8% of patients. Over a median follow-up of 5.6 (interquartile range, 1.4 to 8.5) years, 44.9% of patients failed OMT and underwent intervention (n = 58 open, n = 83 endovascular). The estimated incidence of OMT failure was 46%. Multivariate analysis identified the presence of diabetes, renal failure, DeBakey 3B dissection, and a descending thoracic AD of 4.5 cm or greater (HR, 1.39; 95% confidence interval, 1.24 to 1.56; p < 0.001) to be independent predictors of failure of OMT. FL status or the distribution of visceral vessels arising from the FL did not predict OMT failure. CONCLUSIONS: There is a significant incidence of OMT failure in uTBAD patients. A descending thoracic AD of 4.5 cm or greater at the time of diagnosis is an independent predictor of failure of OMT.
Authors: Bradley G Leshnower; Yazan M Duwayri; Edward P Chen; Chun Li; Carl A Zehner; Jose N Binongo; Ravi K Veeraswamy Journal: Ann Thorac Surg Date: 2016-12-16 Impact factor: 4.330
Authors: Sven Peterss; Ahmed M Mansour; Julia A Ross; Irena Vaitkeviciute; Paris Charilaou; Julia Dumfarth; Hai Fang; Bulat A Ziganshin; John A Rizzo; Adebowale J Adeniran; John A Elefteriades Journal: J Am Coll Cardiol Date: 2016-09-06 Impact factor: 24.094
Authors: Samuel I Schwartz; Christopher Durham; W Darrin Clouse; Virendra I Patel; R Todd Lancaster; Richard P Cambria; Mark F Conrad Journal: J Vasc Surg Date: 2017-09-11 Impact factor: 4.268
Authors: Hunter M Ray; Christopher A Durham; Daniel Ocazionez; Kristofer M Charlton-Ouw; Anthony L Estrera; Charles C Miller; Hazim J Safi; Ali Azizzadeh Journal: J Vasc Surg Date: 2016-10-01 Impact factor: 4.268
Authors: Xiaoying Lou; Edward P Chen; Yazan M Duwayri; Ravi K Veeraswamy; William D Jordan; Carl A Zehner; Bradley G Leshnower Journal: Ann Thorac Surg Date: 2017-08-12 Impact factor: 4.330
Authors: Guido H W van Bogerijen; Jip L Tolenaar; Vincenzo Rampoldi; Frans L Moll; Joost A van Herwaarden; Frederik H W Jonker; Kim A Eagle; Santi Trimarchi Journal: J Vasc Surg Date: 2014-04 Impact factor: 4.268
Authors: Rana O Afifi; Harleen K Sandhu; Samuel S Leake; Mina L Boutrous; Varsha Kumar; Ali Azizzadeh; Kristofer M Charlton-Ouw; Naveed U Saqib; Tom C Nguyen; Charles C Miller; Hazim J Safi; Anthony L Estrera Journal: Circulation Date: 2015-08-25 Impact factor: 29.690